Study of licarbazepine in the treatment of manic episodes of bipolar disorder.

Trial Profile

Study of licarbazepine in the treatment of manic episodes of bipolar disorder.

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Mar 2017

At a glance

  • Drugs Licarbazepine (Primary)
  • Indications Bipolar I disorders
  • Focus Registrational; Therapeutic Use
  • Sponsors Novartis; Novartis Pharmaceuticals
  • Most Recent Events

    • 13 Nov 2007 Status change from recruiting to completed.
    • 29 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top